ORTX | Orchard Therapeutics plc Category: Consumer goods Quick infos Headquarters: United Kingdom Trade prices Volume: Market Cap: 64.35M Prev closed: Open: High: Low: 52 week low: 52 week high: Dividends: Next ER: May 12, 2022 Before Market Opens
Date EPS / Forecast Revenue / Forecast August 11, 2022 May 12, 2022 -0.35 / -0.2486 5.52M / 3.88M Beat! March 30, 2022 -0.29 / -0.2725 483K / 300K Beat! March 17, 2022 - / -0.2725 - / 300K November 4, 2021 -0.29 / -0.2511 1.19M / 4.79M view more Historical Data
Date Price Open High Low Vol Change ER May 11, 2022 0.438 0.440
526.93K -2.47% May 10, 2022 0.449 0.460
259.54K 0.83% May 9, 2022 0.445 0.452
617.37K -2.9% May 6, 2022 0.459 0.510
2.10M -10.25% May 5, 2022 0.511 0.557
583.67K -7.41% May 4, 2022 0.552 0.580
328.67K -4.86% May 3, 2022 0.580 0.550
236.37K 3.06% May 2, 2022 0.563 0.552
313.92K -0.35% Apr 29, 2022 0.565 0.587
599.59K 2.73% Apr 28, 2022 0.550 0.592
1.13M -7.35% view more
News If You Had Bought Orchard Therapeutics' (NASDAQ:ORTX) Shares A Year Ago You Would Be Down 62% finance.yahoo.com Nov 16, 2021 11:31 am Orchard Therapeutics Announces OTL-200 Granted Regenerative Medicine Advanced Therapy (RMAT) Designation by FDA for the Treatment of Metachromatic Leukodystrophy (MLD) finance.yahoo.com Nov 16, 2021 7:00 am Orchard Therapeutics Announces Interim Data for OTL-203 Showing Positive Clinical Results in Multiple Disease Manifestations of Mucopolysaccharidosis Type I Hurler Syndrome (MPS-IH) finance.yahoo.com Nov 16, 2021 7:00 am Orchard Therapeutics Reports 2020 Financial Results and Reviews Recent Accomplishments finance.yahoo.com Nov 16, 2021 7:00 am Health Check: How Prudently Does Orchard Therapeutics (NASDAQ:ORTX) Use Debt? finance.yahoo.com Nov 16, 2021 3:15 am Is Orchard Therapeutics (NASDAQ:ORTX) A Risky Investment? finance.yahoo.com Nov 8, 2021 11:59 am Orchard Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Business Updates finance.yahoo.com Nov 4, 2021 7:45 am Orchard Therapeutics to Present at Multiple Investor Conferences in September 2021 finance.yahoo.com Sep 1, 2021 7:00 am Orchard Therapeutics' MPS-I Gene Therapy Shows Encouraging Action In Early Study, Shares Spike finance.yahoo.com Aug 18, 2021 8:19 am Orchard Therapeutics Announces FDA Clearance of IND Application for OTL-200 for Metachromatic Leukodystrophy (MLD) finance.yahoo.com Aug 18, 2021 7:00 am Orchard Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference finance.yahoo.com Aug 18, 2021 7:00 am Orchard Therapeutics, Pharming Ink Development Pact For Gene Therapy finance.yahoo.com Jul 1, 2021 10:35 am Orchard Therapeutics Issues Updates On Gene Therapy Programs finance.yahoo.com Jun 29, 2021 11:43 am Column: State's biotech partner on a stem cell cure ends the project, but that's good news finance.yahoo.com May 28, 2021 8:12 pm Orchard Therapeutics Reports First Quarter 2021 Financial Results and Provides Recent Business Updates finance.yahoo.com May 13, 2021 7:00 am Be The Match BioTherapies® Announces Expansion of Multi-Year Strategic Alliance with Orchard Therapeutics to Support European Commercial Launch of Libmeldy finance.yahoo.com Mar 3, 2021 9:00 am Orchard Therapeutics Receives Positive CHMP Opinion for Libmeldy for the Treatment of Early-Onset Metachromatic Leukodystrophy (MLD) finance.yahoo.com Nov 16, 2021 6:00 am Orchard Therapeutics Announces New England Journal of Medicine Publication of HSC Gene Therapy Data for ADA-SCID finance.yahoo.com Nov 16, 2021 6:00 am Orchard Therapeutics Outlines Differentiated Profile of Its HSC Gene Therapy Approach and Discusses Potential Future Applications at Virtual R&D Investor Event finance.yahoo.com Sep 14, 2021 6:00 am Orchard Therapeutics to Host Virtual R&D Investor Event on Tuesday, September 14, 2021 finance.yahoo.com Sep 8, 2021 7:00 am Key Persons Talk about Orchard Therapeutics plc below in comments section below.
Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
If you are looking for News & events, Press Release, they are available on their Investors Relationssite.
If you want to help pay for server cost or for improving this tool. You can send it via
Paypal. More features coming soon :) Buy on Amazon
Technical analysis is a collection of techniques designed to help you make trading decisions in securities markets. Technical Analysis For Dummies helps you take a hard-headed look at what securities prices are actually doing rather than what economists or analysts say they should be doing, giving you the know-how to use that data to decide whether to buy or sell individual securities.
A simple, straightforward guide to the fundamentals of technical analysis